References
- SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
- ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
- Endogenous Hormones and Breast Cancer Collaborative GroupKeyTJApplebyPNSex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studiesLancet Oncol201314101009101923890780
- FarvidMSChoEChenWYEliassenAHWillettWCDietary protein sources in early adulthood and breast cancer incidence: prospective cohort studyBMJ2014348g343724916719
- CouchFJHartSNSharmaPInherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerJ Clin Oncol201533430431125452441
- TungNBattelliCAllenBFrequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panelCancer20151211253325186627
- SainiKSLoiSde AzambujaETargeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancerCancer Treat Rev201339893594623643661
- TannheimerSLRehemtullaAEthierSPCharacterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PEBreast Cancer Res20002431132011056689
- HunterDJKraftPJacobsKBA genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerNat Genet200739787087417529973
- Barnholtz-SloanJSShettyPBGuanXFGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger womenCarcinogenesis20103181417142320554749
- LiangJChenPHuZGenetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese womenCarcinogenesis200829122341234618845558
- MaYYWeiSJLinYCPIK3CA as an oncogene in cervical cancerOncogene200019232739274410851074
- EngelmanJAChenLTanXEffective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersNat Med200814121351135619029981
- De RoockWDe VriendtVNormannoNCiardielloFTejparSKRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancerLancet Oncol201112659460321163703
- CampbellIGRussellSEChoongDYMutation of the PIK3CA gene in ovarian and breast cancerCancer Res200464217678768115520168
- OginoSLochheadPGiovannucciEDiscovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiologyOncogene201433232949295523792451
- ParkJYAmankwahEKAnicGMGene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progressionCancer Epidemiology Biomarkers and Prevention2013225827834
- WangLEMaHHaleKSRoles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomesJ Cancer Res Clin Oncol2012138337738522146979
- JaraLGonzalez-HormazabalPCercenoKGenetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American populationBreast Cancer Res Treat2013137255956923225170
- TurnbullCAhmedSMorrisonJGenome-wide association study identifies five new breast cancer susceptibility lociNat Genet201042650450720453838
- ShanJMahfoudhWDsouzaSPGenome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in TunisiansBreast Cancer Res Treat2012135371572422910930
- Penault-LlorcaFBertucciFAdelaideJExpression of FGF and FGF receptor genes in human breast cancerInt J Cancer19956121701767705943
- ZhangJQiuLXWangZHCurrent evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysisBreast Cancer Res Treat2010124241942420300826
- MeyerKBMaiaATO’ReillyMAllele-specific up-regulation of FGFR2 increases susceptibility to breast cancerPLoS Biol200865e10818462018
- HuijtsPEvan DongenMde GoeijMCAllele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10Breast Cancer Res2011134R7221767389
- ChenXHLiXQChenYFengYMRisk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North ChinaBreast Cancer Res Treat2011125257558220640597
- PortaCPaglinoCMoscaATargeting PI3K/Akt/mTOR signaling in cancerFront Oncol201446424782981
- YingJXuQLiuBThe expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosisOnco Targets Ther201582427243326366097
- HaoYSamuelsYLiQOncogenic PIK3CA mutations repro-gram glutamine metabolism in colorectal cancerNat Commun201671197127321283
- SamuelsYWangZBardelliAHigh frequency of mutations of the PIK3CA gene in human cancersScience2004304567055415016963
- KarakasBColakDKayaNPrevalence of PIK3CA mutations and the SNP rs17849079 in Arab breast cancer patientsCancer Biol Ther2013141088889623982433
- StevensKNGarcia-ClosasMFredericksenZEvaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer riskBr J Cancer2011105121934193922033276
- BodnarLStecRCierniakSClinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent linesAnn Oncol20152671385138925962440